Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)
All News about Allogene Therapeutics, Inc. - Common Stock
Allogene Q2 Cash Tops $300 Million ↗
August 13, 2025
Via The Motley Fool
Allogene Narrows Loss in Fiscal Q2 ↗
August 13, 2025
Via The Motley Fool
Via GlobeNewswire